Skip to content
MarketScale

Sciences · Topic

Health Sciences

6 articles from Sciences practitioners

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences initiates what it calls the first Phase I trial of an AI-designed oral drug formulation, approved by the UK's MHRA.

MarketScale Newsroom·Jun 17, 2026
Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I study of an AI-designed oral formulation, cleared by the MHRA—marking a concrete shift from AI experimentation to clin

MarketScale Newsroom·Jun 17, 2026
Why Does Benchmark’s Work Need More Visibility

Why Does Benchmark’s Work Need More Visibility

In an industry defined by rapid scientific breakthroughs, Benchmark Products plays a quietly pivotal role—translating innovation into tangible tools that life sciences manufacturers can actually use. By staying aligned with the evolving needs of patients and producers alike, Benchmark has built a reputation for agility, rapidly manufacturing solutions that improve efficiency and enable new…

Kirk Whitmer·Dec 23, 2025
Expanding Monitoring in Acute Care and Beyond

Expanding Monitoring in Acute Care and Beyond

As hospitals look beyond the ICU to improve outcomes across the entire continuum of care, a key question emerges: how do you expand patient monitoring without overwhelming clinicians with more alarms, more noise, and more work? This episode—part three of a five-part Health and Life Sciences at the Edge series exploring The Future of…

Michelle Dawn Mooney·Dec 16, 2025
AI-Driven Amino Acid Drugs Surface as a Promising Treatment for Eye Conditions

AI-Driven Amino Acid Drugs Surface as a Promising Treatment for Eye Conditions

The rapid evolution of artificial intelligence (AI) promises to revolutionize multiple sectors, and one area seeing tangible benefits is drug development. Historically, the creation of new medicines was a time-consuming endeavor, but AI-driven amino acid research is proving to accelerate the early developmental stages and get drugs to the market faster. Researchers at the Wilmer…

Christopher Clark·Sep 19, 2023
‘Chromatin’ Alteration Technique Has Shown To Destroy Cancer Cells

‘Chromatin’ Alteration Technique Has Shown To Destroy Cancer Cells

The race to cure cancer is an ongoing battle. New research may be showing positive signs for it’s eradication. Researchers with Northwestern University in Illinois may have found a way to kill cancer cells. Follow us on Twitter @ScienceTodayNow for daily updates!

Sciences·Nov 10, 2017
← All Sciences articles

Follow Sciences Insights

Get new expert content in your inbox.

Free workspace

Every article here started as someone's expertise. Yours qualifies.

This coverage is produced through MarketScale with companies across Sciences. The same platform turns your lab directors, applications scientists, and field specialists into the coverage buyers on this page are reading. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system